Are you Dr. Strnad?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
12697 E 51st St
Tulsa, OK 74146Phone+1 918-505-3200Fax+1 918-505-3253
Summary
- Dr. Charles Strnad, MD is an oncologist in Tulsa, Oklahoma. He is currently licensed to practice medicine in Oklahoma and Tennessee. He is affiliated with Saint Francis Hospital.
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1987
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1986
- University of Oklahoma School of Community Medicine (Tulsa)Residency, Internal Medicine, 1981 - 1984
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1981
Certifications & Licensure
- OK State Medical License 1982 - 2021
- TN State Medical License 1984 - 1987
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Publications & Presentations
PubMed
- 15 citationsA phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer.Robert S. Witte, Stuart R. Lipsitz, Thomas L. Goodman, Robert F. Asbury, George Wilding
Investigational New Drugs. 1999-12-22 - 5 citationsHigh-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study.R A Saez, R. B. Slease, C. Strnad, George B. Selby, Dennis L. Confer
Bone Marrow Transplantation. 1995-01-01 - 62 citationsPeritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma.C. M. Strnad, W W Grosh, J. Baxter, L. S. Burnett, Howard W. Jones
Annals of Internal Medicine. 1989-08-01
Professional Memberships
- Member
- Member